EA201390507A1 - Эмульсия циклоспорина - Google Patents

Эмульсия циклоспорина

Info

Publication number
EA201390507A1
EA201390507A1 EA201390507A EA201390507A EA201390507A1 EA 201390507 A1 EA201390507 A1 EA 201390507A1 EA 201390507 A EA201390507 A EA 201390507A EA 201390507 A EA201390507 A EA 201390507A EA 201390507 A1 EA201390507 A1 EA 201390507A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cyclosporin
emulsion
cyclosporin emulsion
phosphatidylcholine
glycerin
Prior art date
Application number
EA201390507A
Other languages
English (en)
Other versions
EA027081B1 (ru
Inventor
Эскил Эльмер
Original Assignee
Ньюроувив Фармасьютикал Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43733181&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201390507(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ньюроувив Фармасьютикал Аб filed Critical Ньюроувив Фармасьютикал Аб
Publication of EA201390507A1 publication Critical patent/EA201390507A1/ru
Publication of EA027081B1 publication Critical patent/EA027081B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

Настоящее изобретение относится к эмульсии циклоспорина, содержащей: i) циклоспорин, ii) натуральное масло (длинноцепочечный триглицерид), iii) фосфатидилхолин, iv) глицерин, v) фармацевтически приемлемую щелочную соль свободной жирной кислоты, vi) масло, содержащее среднецепочечные триглицериды, vii) при необходимости соляную кислоту или гидроксид натрия для доведения значения рН, viii) воду.
EA201390507A 2010-10-01 2011-09-30 Эмульсия циклоспорина EA027081B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38863310P 2010-10-01 2010-10-01
DKPA201000891 2010-10-01
PCT/EP2011/067117 WO2012042023A2 (en) 2010-10-01 2011-09-30 Cyclosporine emulsion

Publications (2)

Publication Number Publication Date
EA201390507A1 true EA201390507A1 (ru) 2013-08-30
EA027081B1 EA027081B1 (ru) 2017-06-30

Family

ID=43733181

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201390507A EA027081B1 (ru) 2010-10-01 2011-09-30 Эмульсия циклоспорина

Country Status (15)

Country Link
US (2) US9040487B2 (ru)
EP (1) EP2621469B1 (ru)
JP (1) JP5860468B2 (ru)
KR (1) KR101801430B1 (ru)
CN (2) CN103118664B (ru)
AU (1) AU2011310111C9 (ru)
CA (1) CA2812901C (ru)
CL (1) CL2013000865A1 (ru)
EA (1) EA027081B1 (ru)
ES (1) ES2597959T3 (ru)
HK (1) HK1208357A1 (ru)
IL (1) IL225300A (ru)
MX (2) MX340897B (ru)
PL (1) PL2621469T3 (ru)
WO (1) WO2012042023A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012128014A1 (ja) * 2011-03-23 2012-09-27 テルモ株式会社 成分測定装置
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
KR101211902B1 (ko) * 2012-04-30 2012-12-13 주식회사 휴온스 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물
CN106456541A (zh) * 2014-02-14 2017-02-22 黄敬珺 纳米乳传递系统组合物
CN104055749B (zh) * 2014-05-27 2017-05-24 无锡曙辉药业有限公司 环孢素a的自微乳化软胶囊内容物组合及其制备方法
CN105267144B (zh) * 2014-07-04 2020-08-18 四川科伦药业股份有限公司 一种环孢素脂肪乳注射液
WO2017147470A1 (en) * 2016-02-26 2017-08-31 The Regents Of The University Of California Bicontinuous microemulsions and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052016T3 (es) 1988-09-29 1994-07-01 Shiseido Co Ltd Composicion emulsionada.
US5527537A (en) * 1992-05-18 1996-06-18 Dietl; Hans Pharmaceutical preparation containing cyclosporine(s) for intravenous administration and a process for its production
JP3200639B2 (ja) 1992-05-19 2001-08-20 カシオ計算機株式会社 薄膜トランジスタパネルの製造方法
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
KR980008239A (ko) 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
DE19961733A1 (de) * 1999-12-21 2001-06-28 Ciclomulsion Ag Cyclosporin(e) enthaltende hypertone pharmazeutische Zubereitung zur Anwendung bei neurologischen Erkrankungen und als Neuroprotektivum sowie Verfahren zu ihrer Herstellung
CA2578176C (en) * 2004-11-09 2013-09-24 Novagali Pharma Sa Ophthalmic emulsions containing an immunosuppressive agent
CN101904814A (zh) * 2009-06-04 2010-12-08 上海恒瑞医药有限公司 制备载药乳剂的方法

Also Published As

Publication number Publication date
US20130323270A1 (en) 2013-12-05
CN103118664B (zh) 2015-11-25
ES2597959T3 (es) 2017-01-24
AU2011310111C1 (en) 2015-05-07
IL225300A0 (en) 2013-06-27
AU2011310111B2 (en) 2014-08-14
CA2812901C (en) 2019-02-19
JP2013538843A (ja) 2013-10-17
AU2011310111B9 (en) 2016-11-24
PL2621469T3 (pl) 2017-01-31
MX340897B (es) 2016-07-29
KR101801430B1 (ko) 2017-11-24
IL225300A (en) 2017-06-29
CA2812901A1 (en) 2012-04-05
CL2013000865A1 (es) 2014-03-28
JP5860468B2 (ja) 2016-02-16
EP2621469B1 (en) 2016-07-20
AU2011310111A1 (en) 2013-04-04
US9040487B2 (en) 2015-05-26
HK1208357A1 (en) 2016-03-04
CN104548064A (zh) 2015-04-29
AU2011310111C9 (en) 2016-11-24
MX336100B (es) 2016-01-08
CN103118664A (zh) 2013-05-22
MX2013003578A (es) 2013-10-25
KR20130124944A (ko) 2013-11-15
WO2012042023A3 (en) 2012-06-21
US20150238563A1 (en) 2015-08-27
EP2621469A2 (en) 2013-08-07
EA027081B1 (ru) 2017-06-30
WO2012042023A2 (en) 2012-04-05

Similar Documents

Publication Publication Date Title
EA201390507A1 (ru) Эмульсия циклоспорина
PH12016500216B1 (en) Stable pharmaceutical composition and methods of using same
CL2013000230A1 (es) Metodos para obtener una composicion oleaginosa a partir de biomasa; y composiciones oleaginosas obtenidas de biomasa acuatica.
EA201290097A1 (ru) Спиртовые композиции, имеющие пониженный риск возникновения ацетальдегидемии
GT201300009A (es) Derivados de tetrahidro-pirido-pirimidina
AR089268A1 (es) Composiciones acuosas para el cuidado bucal
IN2012DN06581A (ru)
FR2940117B1 (fr) Emulsion huile dans eau presentant un ph allant de 3 a 5,5
BR112012004841A2 (pt) método de produção de emulsão de óleo/água
BR112013005881A2 (pt) ''método de produção de um óleo vegetal refinado''
NI201100149A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia.
AR082943A1 (es) Formula nutricional predigerida
EA201600088A1 (ru) Парентеральное введение тапентадола
CR20120261A (es) Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica
RU2016136638A (ru) Применение режима краткосрочного голодания в сочетании с ингибиторами киназ для усовершенствования традиционной химио-лекарственной эффективности и пригодности и обращения вспять побочных эффектов от киназ в нормальных клетках и тканях
AR074545A1 (es) Proceso de preparacion de dihidroetorfina
CY1124624T1 (el) Μητρες οι οποιες περιεχουν εναν τροποποιημενο πολυσακχαριτη
FI20125509A (fi) Modifioitu mäntyöljyrasvahappo
EA201171230A1 (ru) Ингибитор обратного захвата серотонина и норэпинефрина
AR077915A1 (es) Forma cristalina de pemirolast
MY158088A (en) Stable lipid emulsion containing prostaglandin e1
EA201391344A1 (ru) Способ увеличения расхода водной дисперсии
WO2010095877A3 (en) Aqueous nanoemulsion composition containing conjugated linoleic acid
ES2530436T3 (es) Combinación
MX2011007188A (es) Metodos para incrementar niveles de plasmalogenos endogenos.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

TC4A Change in name of a patent proprietor in a eurasian patent